Literature DB >> 7513162

Interleukin-8 production by CD16-CD56bright natural killer cells in the human early pregnancy decidua.

S Saito1, T Kasahara, S Sakakura, M Enomoto, H Umekage, N Harada, T Morii, K Nishikawa, N Narita, M Ichijo.   

Abstract

Decidual CD16-CD56bright natural killer (NK) cells were sorted from the decidual mononuclear cells (MNC) at the early pregnancy using a fluorescence activated cell sortor. The CD16-CD56bright NK cell population occupies a major population in the decidual MNC, in contrast to a very small population (< 1%) in the peripheral blood MNC. These decidual CD16-CD56bright NK cells produced a large amount of IL-8, i. e., mean of 96.7 +/- 19.8 ng/ml in the 24 hr-cultured supernatants without any stimulant, which was comparable to the IL-8 production by LPS-stimulated peripheral blood MNC. Most of the IL-8 was ascribable to the production from decidual CD16-CD56bright NK cells. Intracytoplasmic IL-8 in the decidual CD56bright NK cells was also detected by flow cytometry. RT-PCR methods confirmed IL-8 mRNA expression in this population, while no or very scarce expression of IL-1 alpha and IL-1 beta mRNA was observed. The present study is a first observation revealing that decidual CD16-CD56bright NK cells express IL-8 mRNA and produce IL-8.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513162     DOI: 10.1006/bbrc.1994.1459

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Murine endometrial and decidual NK1.1+ natural killer cells display a B220+CD11c+ cell surface phenotype.

Authors:  Thomas V Mallidi; Laura E Craig; Suzanne R Schloemann; Joan K Riley
Journal:  Biol Reprod       Date:  2009-04-15       Impact factor: 4.285

2.  DBA-lectin reactivity defines mouse uterine natural killer cell subsets with biased gene expression.

Authors:  Zhilin Chen; Jianhong Zhang; Kota Hatta; Patricia D A Lima; Hakim Yadi; Francesco Colucci; Aureo T Yamada; B Anne Croy
Journal:  Biol Reprod       Date:  2012-10-04       Impact factor: 4.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.